| 000 | 01307 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517005206.0 | ||
| 264 | 0 | _c20151105 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a2072-6643 | ||
| 024 | 7 |
_a10.3390/nu6125583 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerolla, Silvia M | |
| 245 | 0 | 0 |
_aThe role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease. _h[electronic resource] |
| 260 |
_bNutrients _cDec 2014 |
||
| 300 |
_a5583-99 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 | _aBacterial Translocation |
| 650 | 0 | 4 | _aHost-Pathogen Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestine, Small _xdrug effects |
| 650 | 0 | 4 | _aMicrobiota |
| 650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xdrug therapy |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aArmiliato, Geyza N A | |
| 700 | 1 | _aCouto, Cláudia A | |
| 700 | 1 | _aFerrari, Teresa C A | |
| 773 | 0 |
_tNutrients _gvol. 6 _gno. 12 _gp. 5583-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/nu6125583 _zAvailable from publisher's website |
| 999 |
_c24432408 _d24432408 |
||